Tumor Interventional Therapy Medical Services in China

Tumor interventional therapy is a minimally invasive, image-guided treatment modality used primarily for solid malignancies—especially hepatocellular carcinoma, renal cell carcinoma, lung cancer, and metastatic liver disease. It encompasses techniques such as transarterial chemoembolization (TACE), radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, and yttrium-90 radioembolization (Y-90). Unlike systemic chemotherapy or open surgery, interventional oncology targets tumors precisely via catheter-based delivery or percutaneous thermal/chemical ablation, preserving healthy tissue and reducing recovery time. It is particularly valuable for patients with unresectable tumors, contraindications to surgery, or those seeking organ-sparing alternatives. Treatment decisions are guided by multidisciplinary tumor boards incorporating contrast-enhanced ultrasound, MRI, and digital subtraction angiography (DSA) for real-time navigation.

China offers distinct advantages in tumor interventional therapy: its leading oncology centers—such as Fudan University Shanghai Cancer Center and Sun Yat-sen University Cancer Center—employ internationally trained interventional radiologists and maintain JCI-accredited facilities equipped with state-of-the-art Siemens Artis Q, Philips Azurion, and advanced ablation platforms. Clinical outcomes align with global benchmarks: five-year survival rates for early-stage HCC treated with TACE plus MWA exceed 60%, supported by robust longitudinal data published in journals like *Hepatology* and *European Radiology*. Crucially, costs are typically 40–60% lower than in the US or Western Europe—without compromising protocol fidelity or device quality. As a dedicated medical tourism agency, we streamline international patient access: verifying hospital credentials, coordinating pre-arrival imaging reviews, securing transparent all-inclusive pricing (covering diagnostics, procedure, anesthesia, and post-procedure monitoring), and providing end-to-end support—from visa assistance and interpreter services to rehabilitation follow-up.

Medical Travel to China Guide: Interventional Oncology

Visa & Entry: Most patients obtain a Medical Visa (Q2 or S2) with our support—providing invitation letters from partner hospitals, appointment confirmations, and translation assistance. Passport validity must exceed six months; processing takes 3–5 business days.

Insurance & Payment: While international health insurance may cover part of treatment, most insurers require pre-authorization for interventional oncology in China. We verify coverage eligibility and help file claims. All treatment packages—including imaging, biopsy, embolization, radiofrequency ablation, and post-procedure monitoring—are quoted transparently upfront, with no hidden fees. Payments can be made securely via wire transfer, credit card, or Alipay (with USD/GBP/EUR conversion). Our team handles billing coordination and provides itemized receipts.

Accommodation & Companions: We arrange hospital-near apartments or partner hotels with kitchen access, Wi-Fi, and English-speaking staff. One companion may stay free in patient rooms (subject to hospital policy); additional guests receive discounted rates.

Follow-Up Care: Post-treatment, we schedule virtual consultations with your Chinese oncologist every 2–4 weeks, share imaging reports in English, and coordinate with your home physician for seamless continuity of care.